Founded in 2019, SeaBeLife is a biotech startup developing drug candidates to block cell necrosis. Today, it’s announced a funding boost of almost €1.4 million financing from Bpifrance.  SeaBeLife specialises in the development of drug candidates that block cellular necrosis in order to protect or regenerate organs affected by severe pathologies – for which there […]

The post Brittany-based biotech startup SeaBeLife picks up €1.4 million appeared first on EU-Startups.